Ravi Natarajan, Ph.D.President at Socrates Biosciences
Dr. Ravi Natarajan completed a Post-doctoral fellowship in the laboratories of Professor K. C. Nicolaou at the Scripps Research Institute in La Jolla, California. His Post-doctoral fellowship encompassed the “Total Synthesis of Vancomycin from basic starting materials”. Prior to his post-doctoral fellowship, Dr. Ravi Natarajan completed his Doctorate in Organic Chemistry from the University of Illinois. Dr. Natarajan started his research career as a medicinal chemist at Merck Research Laboratories in Rahway, NJ. His tenure at Merck resulted in the discovery of 7 clinical candidates of which 3 advanced into phase-2 human clinical trials. More recently Dr. Natarajan has joined hands with Professor Phil Baran to expand the applications of the P-V methodology (originally discovered in the Baran laboratories) to produce stereo-pure oligonucleotides and enable the oligonucleotide community to explore its therapeutic advantages.